IPERBOREAL PHARMA SRL

IPERBOREAL PHARMA SRL logo
🇮🇹Italy
Ownership
Private
Established
2003-01-01
Employees
-
Market Cap
-
Website
http://www.iperboreal.com

Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD

First Posted Date
2019-06-27
Last Posted Date
2023-03-03
Lead Sponsor
Iperboreal Pharma Srl
Target Recruit Count
11
Registration Number
NCT04001036
Locations
🇮🇹

Department of Nephrology, University of Chieti, Chieti, Italy

Peritoneal Ultrafiltration in Cardio Renal Syndrome.

First Posted Date
2019-06-21
Last Posted Date
2024-05-31
Lead Sponsor
Iperboreal Pharma Srl
Target Recruit Count
84
Registration Number
NCT03994874
Locations
🇮🇹

Ospedale Ss. Annunziata, Chieti, Italy

🇮🇹

ASST FBF Sacco, Milano, Italy

🇮🇹

Ospedale Monaldi, Napoli, Italy

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

First Posted Date
2019-06-21
Last Posted Date
2024-06-17
Lead Sponsor
Iperboreal Pharma Srl
Target Recruit Count
170
Registration Number
NCT03994471
Locations
🇮🇹

Ospedale SS. Annunziata, Chieti, Italy

🇮🇹

IRCCS Policlinico San Martino, Genova, Italy

🇮🇹

Ospedale Civile San Salvatore, L'Aquila, Italy

and more 38 locations

L-Carnitine in Peritoneal Dialysis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-06-17
Last Posted Date
2010-02-23
Lead Sponsor
Iperboreal Pharma Srl
Target Recruit Count
4
Registration Number
NCT00922701
Locations
🇮🇹

Division of Nephrology, University of "G. d'Annunzio", Chieti, Italy

Study of Safety and Efficacy on New Peritoneal Dialysis Solutions

First Posted Date
2009-03-09
Last Posted Date
2019-06-26
Lead Sponsor
Iperboreal Pharma Srl
Registration Number
NCT00858182

L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-02-26
Last Posted Date
2019-06-25
Lead Sponsor
Iperboreal Pharma Srl
Target Recruit Count
5
Registration Number
NCT00851838
Locations
🇮🇹

Division of Nephrology, University of "G. d'Annunzio", Chieti, Italy

Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

First Posted Date
2008-09-19
Last Posted Date
2019-06-26
Lead Sponsor
Iperboreal Pharma Srl
Registration Number
NCT00755404
Locations
🇮🇹

Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore, Milano, Italy

🇮🇹

Division of Nephrology and Dialysis, "Mazzini" Hospital, Teramo, Italy

🇮🇹

Nephrology and Dialysis Unit, Desio Hospital, Desio, Italy

and more 5 locations

Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

First Posted Date
2008-09-19
Last Posted Date
2019-06-26
Lead Sponsor
Iperboreal Pharma Srl
Target Recruit Count
35
Registration Number
NCT00755456
Locations
🇮🇹

Renal and Dialysis, Bari Policlinic Hospital, Bari, Italy

🇮🇹

Renal, Dialysis and Transplant Unit, University of Bari, Bari, Italy

🇮🇹

Division of Nephrology, University of "G. d'Annunzio", Chieti, Italy

and more 9 locations
© Copyright 2024. All Rights Reserved by MedPath